Literature DB >> 25662941

Histological subtype of medulloblastoma frequently changes upon recurrence.

Julia Pöschl1, Arend Koch, Ulrich Schüller.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25662941     DOI： 10.1007/s00401-015-1397-0

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  6 in total

Review 1.  Subfrontal recurrence after cerebellar medulloblastoma resection without local relapse: case-based update.

Authors:  He Yue; Wang Ling; Ou Yibo; Wang Sheng; Tang Sicheng; Chen Jincao; Guo Dongsheng
Journal:  Childs Nerv Syst       Date:  2018-06-23       Impact factor: 1.475

Review 2.  p53 and Meduloblastoma.

Authors:  Vijay Ramaswamy; Carolina Nör; Michael D Taylor
Journal:  Cold Spring Harb Perspect Med       Date:  2015-12-18       Impact factor: 6.915

Review 3.  Medulloblastoma: Tumor Biology and Relevance to Treatment and Prognosis Paradigm.

Authors:  Daniel Coluccia; Carlyn Figuereido; Semra Isik; Christian Smith; James T Rutka
Journal:  Curr Neurol Neurosci Rep       Date:  2016-05       Impact factor: 5.081

4.  Characterization of medulloblastoma in Fanconi Anemia: a novel mutation in the BRCA2 gene and SHH molecular subgroup.

Authors:  Evelina Miele; Angela Mastronuzzi; Agnese Po; Andrea Carai; Vincenzo Alfano; Annalisa Serra; Giovanna Stefania Colafati; Luisa Strocchio; Manila Antonelli; Francesca Romana Buttarelli; Massimo Zani; Sergio Ferraro; Amelia Buffone; Alessandra Vacca; Isabella Screpanti; Felice Giangaspero; Giuseppe Giannini; Franco Locatelli; Elisabetta Ferretti
Journal:  Biomark Res       Date:  2015-06-06

5.  Added value of diffusion weighted imaging in pediatric central nervous system embryonal tumors surveillance.

Authors:  Giovanni Morana; Cesar Augusto Alves; Domenico Tortora; Mariasavina Severino; Paolo Nozza; Armando Cama; Marcello Ravegnani; Gabriella D'Apolito; Alessandro Raso; Claudia Milanaccio; Claudia da Costa Leite; Maria Luisa Garrè; Andrea Rossi
Journal:  Oncotarget       Date:  2017-07-25

6.  mTORC1 promotes malignant large cell/anaplastic histology and is a targetable vulnerability in SHH-TP53 mutant medulloblastoma.

Authors:  Valentina Conti; Manuela Cominelli; Valentina Pieri; Alberto L Gallotti; Ilaria Pagano; Matteo Zanella; Stefania Mazzoleni; Flavia Pivetta; Monica Patanè; Giulia M Scotti; Ignazio S Piras; Bianca Pollo; Andrea Falini; Alessio Zippo; Antonella Castellano; Roberta Maestro; Pietro L Poliani; Rossella Galli
Journal:  JCI Insight       Date:  2021-12-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.